by ChampionTeam | Oct 6, 2025 | Peptides
Key Research Findings Semax demonstrates significant neuroprotective effects through μ-opioid receptor modulation and USP18 regulation in spinal cord injury models ACTH(4-7)PGP structure enables enhanced BDNF production and TrkB receptor sensitivity in hippocampal...
by ChampionTeam | Oct 6, 2025 | Peptides
Key Research Findings Selank demonstrates 39.6% reduction in morphine withdrawal syndrome severity in controlled studies This anxiolytic peptide operates through GABA receptor modulation without dependency risk Clinical trials show significant stress response...
by ChampionTeam | Oct 6, 2025 | Peptides
Key Research Findings Phase 2 trials demonstrate up to 24.2% mean weight loss after 48 weeks in obesity research Triple mechanism targets GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects 82% reduction in hepatic steatosis observed in...
by ChampionTeam | Sep 29, 2025 | Peptides
Key Research Findings PT-141 (bremelanotide) demonstrates significant efficacy in treating hypoactive sexual desire disorder through melanocortin 3 and 4 receptor activation Clinical trials show improved Female Sexual Function Index scores with nasal spray...
by ChampionTeam | Sep 29, 2025 | Peptides
Key Research Findings PNC-27 demonstrates selective cytotoxicity with IC₅₀ values of 12.4 μM against cervical cancer cells while sparing normal cells Unique mechanism targets HDM-2 proteins exclusively expressed in cancer cell membranes, not normal cells Laboratory...